Give
Sign In
About
About ASTCT
History of ASTCT
ASTCT Leadership
News and Media
Contact ASTCT
About ASTCT Membership
Practice
Practice Resources
COVID-19 Resources
RFI Forms
Awards and Grants
New Investigator Award
Professional Development
Career & Fellowship Center
Attend
Event Calendar
Tandem Meetings
AcCELLerate Forum
ASTCT-ISCT Cell Therapy Training Course
CTTC Sponsors
Clinical Education Conference
Clinical Research Training Course
Fundamentals of HCT Training Course
Joint ASTCT-EBMT Basic and Translational Scientific Meeting
Leadership Course
ASTCT + EBMT Relapse Conference
Learn
About ASTCT Education
ASTCT Learning Center
ASTCT Publications
ASTCT Talks Podcast
Coding, Billing, and Reimbursement
CAR-T Therapy Coding and Billing Guide
Practice Guidelines
Patient Education
Advocate
ASTCT Advocacy
Advocacy Statements
ACCESS Initiative
Connect
Connect with ASTCT
About ASTCT Membership
ASTCT Member Directory
ASTCT Community
About ASTCT Committees
About ASTCT SIGs
Support
Sponsorship Opportunities
Corporate Council
Learn
PRACTICE GUIDELINES AVAILABLE
ONLINE
OR VIA MOBILE APP FROM
APPLE APP STORE
OR
GOOGLE PLAY
.
CELLULAR THERAPY
Circular of Information for the Use of Cellular Therapy Products
CLINICAL PRACTICE
General
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from ASTCT
Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from ASTCT
Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from ASTCT
Statement on Routine Prophylaxis for Central Nervous System Recurrence of Acute Lymphoblastic Leukemia following Allogeneic Hematopoietic Cell Transplantation
Guidelines for Cord Blood Unit Thaw and Infusion
Hematopoietic Stem Cell Transplantation for Multiple Myeloma
Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation
Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma
First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease
Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation
Infection/Infectious Diseases
Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients
Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by ASTCT
H1N1 Influenza: Guidelines for Transplant Centers and Personnel
Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients
Operations
Transplant Consultation Timing Guidelines (NMDP)
Emergency Preparedness for Hematopoietic Cell Transplant Programs (Anticipating Natural and Man-Made Disasters)
BMT Clinical Social Worker role description
Defining and Implementing Standard Episode of Care for Hematopoietic Stem Cell Transplantation within the Context of Clinical Trials
Joint Public Policy on Legislative and Regulatory Affairs
Cord Blood Registries
TRAINING
Curriculum for an HCT Fellowship Training Program
Search